Complete Wegovy vs Mounjaro UK Dose Comparison Guide
Wegovy vs Mounjaro UK: Complete Dose Range Advantage
When comparing Wegovy vs Mounjaro UK options, having access to every dose throughout your treatment journey is essential for success. EverydayMeds stocks the complete Wegovy dose escalation range: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance doses from week 17 onwards. This comprehensive availability means you can start your weight management programme knowing your pharmacy partner can support you from initial titration through to long-term maintenance. Unlike pharmacies with intermittent stock, our complete dose range ensures treatment continuity without the stress of sourcing your next dose elsewhere.
The importance of uninterrupted dose progression cannot be overstated in Wegovy vs Mounjaro UK comparisons. Both medications require careful dose escalation to minimise gastrointestinal side effects whilst achieving optimal therapeutic benefit. Missing a dose or reverting to lower strengths due to supply issues can compromise your treatment outcomes. Our commitment to stocking every Wegovy dose reflects our understanding that weight management is a long-term commitment requiring reliable pharmaceutical support throughout your entire journey.
Wegovy vs Mounjaro UK Pricing: Complete Cost Breakdown
Understanding the complete cost structure when comparing Wegovy vs Mounjaro UK options helps inform your treatment decision. Our Wegovy pricing reflects the dose escalation schedule: 0.25mg starter doses at £79.99, 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg doses at £209.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers use code DOSE25 for ongoing savings. Our bundle options provide convenient supply security - the Intro Duo (0.25mg & 0.5mg) at £169.99 covers your first 8 weeks, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99.
The value proposition extends beyond individual pen pricing when evaluating Wegovy vs Mounjaro UK costs. Our Getting Started bundles eliminate the need for multiple orders during dose escalation, whilst Take-It-Slow bundles accommodate patients requiring extended time at lower doses. The Consistency range offers convenient same-dose supplies for patients stabilised at their optimal level. This comprehensive pricing structure, combined with our Stock Available availability, provides cost predictability and supply security throughout your treatment programme with this prescription-only medicine.
Wegovy vs Mounjaro UK Clinical Evidence Comparison
The clinical evidence base differs significantly when comparing Wegovy vs Mounjaro UK mechanisms and outcomes. Wegovy contains semaglutide, a GLP-1 receptor agonist that demonstrated substantial weight management benefits in the STEP clinical trial programme. In STEP 1, patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, highlighting additional health benefits beyond weight management.
Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist with its own robust clinical evidence base through the SURMOUNT trial programme. However, direct head-to-head comparisons between Wegovy vs Mounjaro UK outcomes should be interpreted cautiously due to different trial designs, patient populations, and endpoints. Both medications are prescription-only medicines requiring clinical assessment and ongoing medical supervision. Your prescriber can evaluate which mechanism may be most appropriate based on your individual medical history, treatment goals, and response to therapy.
How Wegovy Works: GLP-1 Mechanism in Wegovy vs Mounjaro UK
Understanding the mechanism of action is crucial when evaluating Wegovy vs Mounjaro UK options for weight management. Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone produced in your intestines after eating. This hormone signals to your brain's appetite centres, promoting feelings of fullness and satiety after smaller meals. The medication may help reduce food cravings and the preoccupation with food that many people experience during weight loss attempts. Additionally, Wegovy slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. This multi-faceted approach to appetite regulation, combined with a reduced-calorie diet and increased physical activity, supports sustainable weight management outcomes.
Wegovy vs Mounjaro UK Ordering Process at EverydayMeds
Accessing either option in our Wegovy vs Mounjaro UK comparison begins with our streamlined 3-minute online clinical assessment. This comprehensive questionnaire covers your medical history, current medications, weight management goals, and suitability for prescription treatment. Following submission, our qualified prescribers review your assessment - standard review takes 3 working days, with express 24-hour review available for urgent requirements. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using temperature-controlled, cold-chain packaging to maintain medication integrity. Our clinical team remains available throughout your treatment for dosing guidance, side effect management, and ongoing support as you progress through the dose escalation schedule.
Storage and Practical Considerations: Wegovy vs Mounjaro UK
Practical storage requirements differ when comparing Wegovy vs Mounjaro UK medications, with Wegovy offering superior travel convenience. Wegovy pens must be stored in the refrigerator at 2-8°C before first use but can remain at room temperature below 30°C for up to 6 weeks once removed from refrigeration - significantly longer than Mounjaro's 21-day room temperature limit. Each Wegovy pen uses Novo Nordisk's FlexTouch delivery system, providing consistent, reliable dosing with a pre-filled, single-use design. The pen delivers your prescribed dose through a fine needle, with dose escalation following a mandatory schedule that cannot be accelerated to minimise gastrointestinal side effects. Proper injection technique and site rotation help ensure optimal medication absorption and reduce injection site reactions throughout your treatment journey.
Long-term Treatment Planning: Wegovy vs Mounjaro UK Dose Escalation
Successful weight management requires long-term planning, making the Wegovy vs Mounjaro UK dose availability question particularly relevant for sustained treatment outcomes. Wegovy's dose escalation follows a structured 16-week titration schedule before reaching the 2.4mg maintenance dose, with each stage serving specific physiological and tolerability purposes. Patients typically remain on the 2.4mg maintenance dose long-term, making reliable supply of this strength essential for continued success. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply, offering peace of mind for established patients who have completed dose escalation.
The importance of pharmacy consistency throughout your Wegovy vs Mounjaro UK treatment journey cannot be understated, particularly given that weight regain commonly occurs if treatment is discontinued. Clinical evidence demonstrates that patients may regain approximately two-thirds of lost weight within one year of stopping Wegovy treatment, emphasising that weight management represents a long-term health commitment rather than a temporary intervention. By ensuring complete dose availability from treatment initiation through long-term maintenance, EverydayMeds supports your commitment to sustained weight management success.
Expert Support for Your Wegovy vs Mounjaro UK Decision
Making an informed choice in the Wegovy vs Mounjaro UK comparison requires expert clinical guidance tailored to your individual circumstances. Our experienced prescribers evaluate multiple factors including your medical history, previous weight management attempts, concurrent medications, and specific health goals when recommending treatment options. Both medications are prescription-only medicines requiring ongoing medical supervision, regular monitoring, and dose adjustments based on your response and tolerability. We provide comprehensive patient education materials covering injection technique, side effect management, dietary guidance, and realistic expectation setting to optimise your treatment experience. Whether you begin with Wegovy's proven GLP-1 mechanism or explore Mounjaro's dual agonist approach, our clinical team ensures you receive appropriate support throughout your weight management journey with either option available through our complete dose range at competitive UK pricing. New customers can start their assessment today using discount code FIRST40, with returning patients applying DOSE25 at checkout for ongoing savings on this life-changing prescription-only medicine.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
